A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease

Annals of Neurology

Volumn 44, Issue 3 SUPPL. 1, 1998, Pages

  Tatton, Nadine A ^a   Maclean Fraser, A ^a   Tatton, William G ^a   Perl, Daniel P ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CONFERENCE PAPER; DNA STRAND BREAKAGE; FLUORESCENCE; HUMAN; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031696403     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440721     Document Type: Conference Paper

References (45)

1. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996; 137:120-123
2. Dragunow M, Faull RL, Lawlor P, et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995;6:1053-1057
3. Kosel S, Egensperger R, Eitzen U, Mehraein P, Graeber MB. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 1997;93:105-108
4. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997;12:25-31
5. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 1997;77:1037-1048
6. Kroemer G, Zamzani N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:43-51
7. Rossiter JP, Riopelle RJ, Bisby MA. Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons: time course analysis and relation to NADPH-diaphorase activity. Exp Neurol 1996;138:33-44
8. Tatton WG, Ju WY, Holland DP, Tai C, Kwan M. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 1994;63:1572-1575
9. Zamzami N, Marchetti P, Castedo M, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995;181: 1661-1672
10. Enokido Y, Araki T, Tanaka K, Aizawa S, Hatanaka H. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur J Neurosci 1996;8:1812-1821
11. +) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 1994; 170:191-194
12. Chinnaiyan AM, Dixit VM. Portrait of an executioner: the molecular mechanism of Fas/APO-1-induced apoptosis. Semin Immunol 1997;9:69-76
13. Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst 1997;89: 783-789
14. Polla BS, Jacquier-Sarlin MR, Kantengwa S, et al. TNF-alpha alters mitochondrial membrane potential L929 but not in TNF alpha-resistant L929.12 cells: relationship with the expression of stress proteins, annexin 1 and superoxide dismutase activity. Free Rad Res 1996;25:125-131
15. Schapira AH. Mitochondrial disorders. Curr Opin Neurol 1997;10:43-47
16. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996;47(Suppl 3):S161-170
17. Zilkha-Falb R, Ziv I, Nardi N, Offen D, Melamed E, Barzilai A. Monoamine-induced apoptotic neuronal cell death. Cell Mol Neurobiol 1997;17:101-118
18. Ziv I, Zilkha FR, Offen D, Shirvan A, Barzilai A, Melamed E. Levodopa induces apoptosis in cultured neuronal cells - a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov Disord 1997;12:17-23
19. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336
20. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-543
21. Hawkins CJ, Vaux DL. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system. Semin Immunol 1997;9:25-33
22. Jacobson MD, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 1994; 13:1899-1910
23. Wadia JS, Chalmers-Redman RME, Ju WJH, et al. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci 1998;18: 932-947
24. Zamzami N, Susin SA, Marchetti P. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544
25. Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-1160
26. Castedo M, Hirsch T, Susin SA, et al. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996;157:512-521
27. Cossarizza A, Franceschi C, Monti D. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single cell level. Exp Cell Res 1995;220: 232-240
28. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that the 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997;17:5089-5100
29. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonsim in baboons. 1996; 2:1017-1021
30. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-305
31. Kerr JFR, Searle J, Harmon BV, Bishop CJ. Apoptosis. In: Potten CS, ed. Perspectives on mammalian cell death. Oxford: Oxford University Press, 1987:93-128
32. Kerr JFR, Wyllie AH, Currie AR. Apoptosis, a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257
33. Sanders EJ, Wride MA. Programmed cell death in development. Int Rev Cytol 1995;163:105-156
34. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Methods Achiev Exp Pathol 1988;13:18-54
35. Schultze-Osthoff K, Walcak H, Dioge W, Krammer PH. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994;15-20
36. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in-situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
37. Ben-Sasson SA, Sherman Y, Gavrieli Y. Identification of dying cells-in situ staining. Methods Cell Biol 1995;46:29-39
38. Tabor S, Struhl K, Scharf SJ, Gelfand DH. Enzymatic manipulation of DNA and RNA. In: Current protocols in molecular biology. New York: Wiley & Sons, 1997:3.0.1-3.19.6
39. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997;115:1031-1035
40. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-1130
41. Troost D, Aten J, Morsink F, de Jong JMBV. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 1995;21:498-504
42. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995;15:3775-3787
43. Hirons GT, Fawcett JJ, Crissman HA. TOTO and YOYO: new very bright fluorochromes for DNA content analyses by flow cytometry. Cytometry 1994;15:129-140
44. Davison FD, Groves M, Scaravilli F. The effect of formalin fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA. Histochem J 1995;27:983-988
45. Lucassen PJ, Chung WCJ, Vermeulen JP, Campagne MVL, Dierendonck JHV, Swaab DF. Microwave-enhanced in situ end-labeling of fragmented DNA: Parametric studies in relation to postmortem delay and fixation of rat and human brain. J Histochem Cytochem 1995;43:1163-1171